Interestingly, our GSEA analyses in GBM patients (Fig. 4) demonstrated associations between CDH3‐correlated genes and β‐catenin‐dependent WNT pathway, described to be associated with GBM aggressiveness [57]. Here, CDH3 is linked to glioblastoma.